 | • レポートコード：QYR9ST03007 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の予防喘息薬市場について調査・分析し、以下の構成でお届け致します。予防喘息薬の種類別には、ソマトスタチンアナログ、標的療法、化学療法に、用途別には、病院、診療所、腫瘍センターに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別予防喘息薬売上データ ・地域別予防喘息薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別予防喘息薬市場規模：ソマトスタチンアナログ、標的療法、化学療法 ・用途別予防喘息薬市場規模：病院、診療所、腫瘍センター ・主要メーカーの企業情報：Xiaflex、Novartis AG、Roche、Molecular Insight Pharmaceuticals、Callisto Pharmaceuticals ・予防喘息薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Drugs for asthma attacks are bronchodilators. The products include pills, potions, inhalers and sprays. The effect is bronchiectasis, which can relieve asthma symptoms quickly and help prevent asthma attacks. This kind of medicine works well and is quite safe. But be careful not to overuse it. The main side effect is heartbeat. Commonly used are salbutamol (Salbutamol), terbutaline (Terbutaline) and so on. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Preventive Asthma Drug in US$ by the following Product Segments: Somatostatin Analogs, Targeted Therapy, Chemotherapy
Company profiles are primarily based on public domain information including company
Xiaflex
Novartis AG
Roche
Molecular Insight pharmaceuticals
Callisto Pharmaceuticals
The global Preventive Asthma Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Preventive Asthma Drug market based on company, product type, end user and key regions.
This report studies the global market size of Preventive Asthma Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Preventive Asthma Drug in these regions.
This research report categorizes the global Preventive Asthma Drug market by top players/brands, region, type and end user. This report also studies the global Preventive Asthma Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Xiaflex
Novartis AG
Roche
Molecular Insight Pharmaceuticals
Callisto Pharmaceuticals
Market size by Product
Somatostatin Analogs
Targeted Therapy
Chemotherapy
Market size by End User
Hospital
Clinics
Oncology Centres
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Preventive Asthma Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Preventive Asthma Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Preventive Asthma Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Preventive Asthma Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Preventive Asthma Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Preventive Asthma Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Preventive Asthma Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Preventive Asthma Drug Market Size Growth Rate by Product
1.4.2 Somatostatin Analogs
1.4.3 Targeted Therapy
1.4.4 Chemotherapy
1.5 Market by End User
1.5.1 Global Preventive Asthma Drug Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Oncology Centres
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Preventive Asthma Drug Market Size
2.1.1 Global Preventive Asthma Drug Revenue 2014-2025
2.1.2 Global Preventive Asthma Drug Sales 2014-2025
2.2 Preventive Asthma Drug Growth Rate by Regions
2.2.1 Global Preventive Asthma Drug Sales by Regions
2.2.2 Global Preventive Asthma Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Preventive Asthma Drug Sales by Manufacturers
3.1.1 Preventive Asthma Drug Sales by Manufacturers
3.1.2 Preventive Asthma Drug Sales Market Share by Manufacturers
3.1.3 Global Preventive Asthma Drug Market Concentration Ratio (CR5 and HHI)
3.2 Preventive Asthma Drug Revenue by Manufacturers
3.2.1 Preventive Asthma Drug Revenue by Manufacturers (2014-2019)
3.2.2 Preventive Asthma Drug Revenue Share by Manufacturers (2014-2019)
3.3 Preventive Asthma Drug Price by Manufacturers
3.4 Preventive Asthma Drug Manufacturing Base Distribution, Product Types
3.4.1 Preventive Asthma Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Preventive Asthma Drug Product Type
3.4.3 Date of International Manufacturers Enter into Preventive Asthma Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Preventive Asthma Drug Sales by Product
4.2 Global Preventive Asthma Drug Revenue by Product
4.3 Preventive Asthma Drug Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Preventive Asthma Drug Breakdown Data by End User
6 North America
6.1 North America Preventive Asthma Drug by Countries
6.1.1 North America Preventive Asthma Drug Sales by Countries
6.1.2 North America Preventive Asthma Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Preventive Asthma Drug by Product
6.3 North America Preventive Asthma Drug by End User
7 Europe
7.1 Europe Preventive Asthma Drug by Countries
7.1.1 Europe Preventive Asthma Drug Sales by Countries
7.1.2 Europe Preventive Asthma Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Preventive Asthma Drug by Product
7.3 Europe Preventive Asthma Drug by End User
8 Asia Pacific
8.1 Asia Pacific Preventive Asthma Drug by Countries
8.1.1 Asia Pacific Preventive Asthma Drug Sales by Countries
8.1.2 Asia Pacific Preventive Asthma Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Preventive Asthma Drug by Product
8.3 Asia Pacific Preventive Asthma Drug by End User
9 Central & South America
9.1 Central & South America Preventive Asthma Drug by Countries
9.1.1 Central & South America Preventive Asthma Drug Sales by Countries
9.1.2 Central & South America Preventive Asthma Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Preventive Asthma Drug by Product
9.3 Central & South America Preventive Asthma Drug by End User
10 Middle East and Africa
10.1 Middle East and Africa Preventive Asthma Drug by Countries
10.1.1 Middle East and Africa Preventive Asthma Drug Sales by Countries
10.1.2 Middle East and Africa Preventive Asthma Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Preventive Asthma Drug by Product
10.3 Middle East and Africa Preventive Asthma Drug by End User
11 Company Profiles
11.1 Xiaflex
11.1.1 Xiaflex Company Details
11.1.2 Company Business Overview
11.1.3 Xiaflex Preventive Asthma Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Xiaflex Preventive Asthma Drug Products Offered
11.1.5 Xiaflex Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Company Business Overview
11.2.3 Novartis AG Preventive Asthma Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis AG Preventive Asthma Drug Products Offered
11.2.5 Novartis AG Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Business Overview
11.3.3 Roche Preventive Asthma Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Roche Preventive Asthma Drug Products Offered
11.3.5 Roche Recent Development
11.4 Molecular Insight Pharmaceuticals
11.4.1 Molecular Insight Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Molecular Insight Pharmaceuticals Preventive Asthma Drug Products Offered
11.4.5 Molecular Insight Pharmaceuticals Recent Development
11.5 Callisto Pharmaceuticals
11.5.1 Callisto Pharmaceuticals Company Details
11.5.2 Company Business Overview
11.5.3 Callisto Pharmaceuticals Preventive Asthma Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Callisto Pharmaceuticals Preventive Asthma Drug Products Offered
11.5.5 Callisto Pharmaceuticals Recent Development
12 Future Forecast
12.1 Preventive Asthma Drug Market Forecast by Regions
12.1.1 Global Preventive Asthma Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Preventive Asthma Drug Revenue Forecast by Regions 2019-2025
12.2 Preventive Asthma Drug Market Forecast by Product
12.2.1 Global Preventive Asthma Drug Sales Forecast by Product 2019-2025
12.2.2 Global Preventive Asthma Drug Revenue Forecast by Product 2019-2025
12.3 Preventive Asthma Drug Market Forecast by End User
12.4 North America Preventive Asthma Drug Forecast
12.5 Europe Preventive Asthma Drug Forecast
12.6 Asia Pacific Preventive Asthma Drug Forecast
12.7 Central & South America Preventive Asthma Drug Forecast
12.8 Middle East and Africa Preventive Asthma Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Preventive Asthma Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Preventive Asthma Drug Product Picture
Table Preventive Asthma Drug Market Segments
Table Key Manufacturers Preventive Asthma Drug Covered
Table Global Preventive Asthma Drug Market Size Growth Rate by Product 2019-2025 (Units) & (Million US$)
Figure Global Preventive Asthma Drug Sales Market Share by Product 2014-2025
Figure Somatostatin Analogs Product Picture
Table Major Manufacturers of Somatostatin Analogs
Figure Targeted Therapy Product Picture
Table Major Manufacturers of Targeted Therapy
Figure Chemotherapy Product Picture
Table Major Manufacturers of Chemotherapy
Table Global Preventive Asthma Drug Market Size Growth Rate by End User 2019-2025 (Units)
Figure Hospital
Figure Clinics
Figure Oncology Centres
Figure Preventive Asthma Drug Report Years Considered
Figure Global Preventive Asthma Drug Market Size 2014-2025 (Million US$)
Figure Global Preventive Asthma Drug Sales 2014-2025 (Units)
Table Global Preventive Asthma Drug Market Size by Regions 2014-2019 (Units) & (Million US$)
Table Global Preventive Asthma Drug Sales by Regions 2014-2019 (Units)
Table Global Preventive Asthma Drug Sales Market Share by Regions 2014-2019
Figure Global Preventive Asthma Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Preventive Asthma Drug Sales Market Share by Regions
Table Global Preventive Asthma Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Preventive Asthma Drug Revenue Market Share by Regions 2014-2019
Figure Global Preventive Asthma Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Preventive Asthma Drug Revenue Market Share by Regions
Table Global Preventive Asthma Drug Sales by Manufacturers (2014-2019) (Units)
Table Global Preventive Asthma Drug Sales Share by Manufacturers (2014-2019)
Figure Global Preventive Asthma Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Preventive Asthma Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Preventive Asthma Drug Revenue Share by Manufacturers (2014-2019)
Figure Preventive Asthma Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Preventive Asthma Drug Price (2014-2019) (USD/Unit)
Table Preventive Asthma Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Preventive Asthma Drug Product Type
Table Date of International Manufacturers Enter into Preventive Asthma Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Preventive Asthma Drug Sales by Product (2014-2019) (Units)
Table Global Preventive Asthma Drug Sales Share by Product (2014-2019)
Figure Global Preventive Asthma Drug Sales Market Share by Product (2014-2019)
Figure Global Preventive Asthma Drug Sales Market Share by Product in 2018
Table Global Preventive Asthma Drug Revenue by Product (2014-2019) (Million US$)
Table Global Preventive Asthma Drug Revenue Share by Product (2014-2019)
Figure Global Preventive Asthma Drug Revenue Market Share by Product (2014-2019)
Figure Global Preventive Asthma Drug Revenue Market Share by Product in 2018
Table Preventive Asthma Drug Price by Product 2014-2019 (USD/Unit)
Table Global Preventive Asthma Drug Sales by End User (2014-2019) (Units)
Table Global Preventive Asthma Drug Sales Share by End User (2014-2019)
Figure Global Sales Preventive Asthma Drug Market Share by End User (2014-2019)
Figure Global Sales Preventive Asthma Drug Market Share by End User in 2018
Figure North America Preventive Asthma Drug Sales Growth Rate 2014-2019 (Units)
Figure North America Preventive Asthma Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Preventive Asthma Drug Sales by Countries (2014-2019) (Units)
Table North America Preventive Asthma Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Preventive Asthma Drug Sales Market Share by Countries
Table North America Preventive Asthma Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Preventive Asthma Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Preventive Asthma Drug Revenue Market Share by Countries
Figure United States Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure United States Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Units)
Figure Canada Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Canada Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Mexico Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Preventive Asthma Drug Sales by Product (2014-2019) (Units)
Table North America Preventive Asthma Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Preventive Asthma Drug Market Share by Product
Table North America Preventive Asthma Drug Sales by End User (2014-2019) (Units)
Table North America Preventive Asthma Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Preventive Asthma Drug Market Share by End User
Figure Europe Preventive Asthma Drug Sales Growth Rate 2014-2019 (Units)
Figure Europe Preventive Asthma Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Preventive Asthma Drug Sales by Countries (2014-2019) (Units)
Table Europe Preventive Asthma Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Preventive Asthma Drug Sales Market Share by Countries
Table Europe Preventive Asthma Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Preventive Asthma Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Preventive Asthma Drug Revenue Market Share by Countries
Figure Germany Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Germany Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure France Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure UK Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Italy Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Russia Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Preventive Asthma Drug Sales by Product (2014-2019) (Units)
Table Europe Preventive Asthma Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Preventive Asthma Drug Market Share by Product
Table Europe Preventive Asthma Drug Sales by End User (2014-2019) (Units)
Table Europe Preventive Asthma Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Preventive Asthma Drug Market Share by End User
Figure Asia Pacific Preventive Asthma Drug Sales Growth Rate 2014-2019 (Units)
Figure Asia Pacific Preventive Asthma Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Preventive Asthma Drug Sales by Countries (2014-2019) (Units)
Table Asia Pacific Preventive Asthma Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Preventive Asthma Drug Sales Market Share by Countries
Table Asia Pacific Preventive Asthma Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Preventive Asthma Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Preventive Asthma Drug Revenue Market Share by Countries
Figure China Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure China Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Japan Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Korea Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure India Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Australia Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Indonesia Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Malaysia Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Philippines Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Thailand Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Vietnam Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Singapore Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Preventive Asthma Drug Sales by Product (2014-2019) (Units)
Table Asia Pacific Preventive Asthma Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Preventive Asthma Drug Market Share by Product
Table Asia Pacific Preventive Asthma Drug Sales by End User (2014-2019) (Units)
Table Asia Pacific Preventive Asthma Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Preventive Asthma Drug Market Share by End User
Figure Central & South America Preventive Asthma Drug Sales Growth Rate 2014-2019 (Units)
Figure Central & South America Preventive Asthma Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Preventive Asthma Drug Sales by Countries (2014-2019) (Units)
Table Central & South America Preventive Asthma Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Preventive Asthma Drug Sales Market Share by Countries
Table Central & South America Preventive Asthma Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Preventive Asthma Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Preventive Asthma Drug Revenue Market Share by Countries
Figure Brazil Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Brazil Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Argentina Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Preventive Asthma Drug Sales by Product (2014-2019) (Units)
Table Central & South America Preventive Asthma Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Preventive Asthma Drug Market Share by Product
Table Central & South America Preventive Asthma Drug Sales by End User (2014-2019) (Units)
Table Central & South America Preventive Asthma Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Preventive Asthma Drug Market Share by End User
Figure Middle East and Africa Preventive Asthma Drug Sales Growth Rate 2014-2019 (Units)
Figure Middle East and Africa Preventive Asthma Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Preventive Asthma Drug Sales by Countries (2014-2019) (Units)
Table Middle East and Africa Preventive Asthma Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Preventive Asthma Drug Sales Market Share by Countries
Table Middle East and Africa Preventive Asthma Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Preventive Asthma Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Preventive Asthma Drug Revenue Market Share by Countries
Figure GCC Countries Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure GCC Countries Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Turkey Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure Egypt Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Preventive Asthma Drug Sales Growth Rate (2014-2019) (Units)
Figure South Africa Preventive Asthma Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Preventive Asthma Drug Sales by Product (2014-2019) (Units)
Table Middle East and Africa Preventive Asthma Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Preventive Asthma Drug Market Share by Product
Table Middle East and Africa Preventive Asthma Drug Sales by End User (2014-2019) (Units)
Table Middle East and Africa Preventive Asthma Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Preventive Asthma Drug Market Share by End User
Table Xiaflex Company Details
Table Xiaflex Preventive Asthma Drug Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Xiaflex Recent Development
Table Novartis AG Company Details
Table Novartis AG Preventive Asthma Drug Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Recent Development
Table Roche Company Details
Table Roche Preventive Asthma Drug Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Molecular Insight Pharmaceuticals Company Details
Table Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Molecular Insight Pharmaceuticals Recent Development
Table Callisto Pharmaceuticals Company Details
Table Callisto Pharmaceuticals Preventive Asthma Drug Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Callisto Pharmaceuticals Recent Development
Table Global Preventive Asthma Drug Sales Forecast by Regions 2019-2025 (Units)
Table Global Preventive Asthma Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Preventive Asthma Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Preventive Asthma Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Preventive Asthma Drug Sales Forecast by Product 2019-2025 (Units)
Table Global Preventive Asthma Drug Sales Market Share Forecast by Product 2019-2025
Table Global Preventive Asthma Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Preventive Asthma Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Preventive Asthma Drug Sales Forecast by End User 2019-2025 (Units)
Table Global Preventive Asthma Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Preventive Asthma Drug Sales Growth Rate Forecast (2019-2025) (Units)
Figure North America Preventive Asthma Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Preventive Asthma Drug Sales Growth Rate Forecast (2019-2025) (Units)
Figure Europe Preventive Asthma Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Preventive Asthma Drug Sales Growth Rate Forecast (2019-2025) (Units)
Figure Asia Pacific Preventive Asthma Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Preventive Asthma Drug Sales Growth Rate Forecast (2019-2025) (Units)
Figure Central & South America Preventive Asthma Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Preventive Asthma Drug Sales Growth Rate Forecast (2019-2025) (Units)
Figure Middle East and Africa Preventive Asthma Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Preventive Asthma Drug Value Chain
Table Preventive Asthma Drug Customers List
Table Preventive Asthma Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
喘息及びCOPD薬の世界市場：インサイト・予測 Asthma and chronic obstructive pulmonary disease (Asthma/COPD) are a common type of chronic disease. Once they are sick, they usually need long-term medication, which seriously affects people's quality of life.The 2016 Global Asthma Prevention Initiative (GINA) organization has re-released its Conse…- 世界のCOPD・喘息治療薬市場：動向・競争分析 The COPD and Asthma Drug Devices market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for…
- 喘息装置の世界市場：インサイト・予測 Asthma is a type of chronic lung disease that inflames and narrows the airways. The symptoms of the disease are inclusive of recurring periods of wheezing, shortness of breath, chest tightness, and coughing. Asthma inhalers are the medical devices which deliver medication to the patient’s body via t…
- オンサイト予防ケアの世界市場：市場規模・現状・予測 On-site preventive care provides administrations with treatment options for their employees and representative services pertaining to healthcare in their work place. These on-site services tend to diminish the rate of services used by the employees on off-site preventive care. The services that are …
- 喘息及びCOPD薬の世界市場：インサイト・予測 Asthma is a chronic respiratory disease blocking the airways of lung because of inflammation, mucus production, tighten of muscles. Chronic Obstructive Pulmonary Disease(COPD) is caused by obstruction in the airways causing difficulty in breathing, with the primary cause as tobacco smoking.The Globa…